Vimarsana
Biggest News Aggregation in the World

Page 28 - Project Bioshield News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Project Bioshield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Project Bioshield Today - Breaking & Trending Today

Soligenix Corporate Update Letter - Key Highlights and Upcoming Catalysts - Vimarsana News

Soligenix Corporate Update Letter - Key Highlights and Upcoming Catalysts

Published: January 10, 2022

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Source: prnewswire.com
Related Topics:
San DiegoUnited StatesNew JerseyUnited KingdomWhite HouseDistrict Of ColumbiaChristopherj SchaberPontifax MedisonNeal BhatiaAxel LehrerUs CongressEmergent Manufacturing Operations BaltimorePublic Health Solutions Business SegmentEmergent Product Development GaithersburgNational Institute Of AllergyEmergent Biosolutions IncAmerican Arbitration Association In MercerSoligenix IncClinical Dermatology At Therapeutics ResearchDefense Threat Reduction AgencyPhase Ii Small Business Innovation ResearchUs DevelopmentNational Institutes Of HealthBiomedical Advanced ResearchPrnewswire Soligenix Inc
Soligenix to Present at Upcoming Investor Conferences - Vimarsana News

Soligenix to Present at Upcoming Investor Conferences

Published: January 6, 2022

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Source: prnewswire.com
Related Topics:
Hc Wainwright BioconnectUs CongressUs DevelopmentBiomedical Advanced ResearchNational Institute Of AllergyDevelopment AuthorityExchange CommissionSoligenix IncOur Public Health SolutionsDefense Threat Reduction AgencyBioconnect ConferenceInvestor ConferenceBiotech Showcase ConferencePublic Health SolutionsNational InstituteInfectious DiseasesProject BioshieldPriority Review Voucher
Dusquetide Demonstrates Positive Anti-tumor Efficacy in Multiple Nonclinical Animal Studies - Vimarsana News

Dusquetide Demonstrates Positive Anti-tumor Efficacy in Multiple Nonclinical Animal Studies

Published: January 4, 2022

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Source: prnewswire.com
Related Topics:
United KingdomRobert HancockB Brett FinlayUs CongressUs DevelopmentBiomedical Advanced ResearchNational Institute Of AllergyPrnewswire Soligenix IncDevelopment AuthorityRegulatory AgencyExchange CommissionUniversity Of British ColumbiaSoligenix IncOur Public Health SolutionsDefense Threat Reduction AgencyAbout DusquetideFast Track DesignationPromising Innovative MedicineOrphan Drug DesignationsBritish ColumbiaPublic Health SolutionsNational InstituteInfectious DiseasesProject BioshieldPriority Review Voucher
Dusquetide Demonstrates Positive Anti-tumor Efficacy in Multiple Nonclinical Animal Studies - Vimarsana News

Dusquetide Demonstrates Positive Anti-tumor Efficacy in Multiple Nonclinical Animal Studies

Published: January 4, 2022

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Source: prnewswire.com
Related Topics:
United KingdomRobert HancockB Brett FinlayUs CongressUs DevelopmentBiomedical Advanced ResearchNational Institute Of AllergyPrnewswire Soligenix IncDevelopment AuthorityRegulatory AgencyExchange CommissionUniversity Of British ColumbiaSoligenix IncOur Public Health SolutionsDefense Threat Reduction AgencyAbout DusquetideFast Track DesignationPromising Innovative MedicineOrphan Drug DesignationsBritish ColumbiaPublic Health SolutionsNational InstituteInfectious DiseasesProject BioshieldPriority Review Voucher
Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine - Vimarsana News

Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine

Published: December 2, 2021

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Source: prnewswire.com
Related Topics:
United StatesUniversity Of Hawaii At ManoaUniversity Of Colorado CenterWhite HouseDistrict Of ColumbiaOreola DoniniAxel LehrerTheodore RandolphUs CongressUniversity Of HawaiNational Institute Of HealthSmall Business Innovation ResearchNational Institute Of AllergySkaggs School Of PharmacyJohna Burns School Of MedicineSoligenix IncDepartment Of ChemicalDefense Threat Reduction AgencyUniversity Of HawaiiCenters For DiseaseCompany Public Health SolutionsUs DevelopmentPrnewswire Soligenix IncBiomedical Advanced ResearchUniversity Of Colorado Anschutz Medical Campus